Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Drug-induced prolongation of the QT interval.

Roden DM.

N Engl J Med. 2004 Mar 4;350(10):1013-22. Review. No abstract available.

PMID:
14999113
2.

[Drug induced QT prolongation].

Altmann D, Eggmann U, Ammann P.

Wien Klin Wochenschr. 2008;120(5-6):128-35. doi: 10.1007/s00508-008-0940-6. Review. German.

PMID:
18365152
3.

Drug-induced prolongation of the QT interval.

Cruciani RA, Portenoy RK, Homel P.

N Engl J Med. 2004 Jun 17;350(25):2618-21; author reply 2618-21. No abstract available.

PMID:
15208786
4.

Drug-induced prolongation of the QT interval.

Curigliano G, Cipolla C, de Braud F.

N Engl J Med. 2004 Jun 17;350(25):2618-21; author reply 2618-21. No abstract available.

PMID:
15208787
5.

Drug-induced prolongation of the QT interval.

Viskin S, Justo D, Zeltser D.

N Engl J Med. 2004 Jun 17;350(25):2618-21; author reply 2618-21. No abstract available.

PMID:
15208785
6.

Intracoronary acetylcholine-induced prolongation of the QT interval and Torsade des Pointes in long QT interval syndrome.

Aizawa Y, Matsubara T, Higuchi K, Washizuka T, Tamura Y, Uchiyama H, Igarashi Y, Shibata A.

Jpn Heart J. 1994 Sep;35(5):683-8.

PMID:
7830332
7.

[Why is QT interval interesting?].

Elming H, Sonne J, Lublin HK.

Ugeskr Laeger. 2002 Feb 4;164(6):750-4. Review. Danish.

PMID:
11851179
8.

Towards a drug concentration effect relationship for QT prolongation and torsades de pointes.

Webster R, Leishman D, Walker D.

Curr Opin Drug Discov Devel. 2002 Jan;5(1):116-26. Review.

PMID:
11865665
9.

Drug-induced at interval prolongation: clinical, safety and regulatory updaes.

Di Girolamo G.

Curr Drug Saf. 2010 Jan;5(1):41-3. No abstract available.

PMID:
20218963
10.

Clinical relevance and management of drug-related QT interval prolongation.

Crouch MA, Limon L, Cassano AT.

Pharmacotherapy. 2003 Jul;23(7):881-908. Review.

PMID:
12885102
11.

Early afterdepolarizationlike activity in patients with class IA induced long QT syndrome and torsades de pointes.

Kurita T, Ohe T, Shimizu W, Suyama K, Aihara N, Takaki H, Kamakura S, Shimomura K.

Pacing Clin Electrophysiol. 1997 Mar;20(3 Pt 1):695-705.

PMID:
9080496
12.

The canine Purkinje fiber: an in vitro model system for acquired long QT syndrome and drug-induced arrhythmogenesis.

Gintant GA, Limberis JT, McDermott JS, Wegner CD, Cox BF.

J Cardiovasc Pharmacol. 2001 May;37(5):607-18.

PMID:
11336111
13.

A new preclinical biomarker for risk of Torsades de Pointes: drug-induced reduction of the cardiac electromechanical window.

Vargas HM.

Br J Pharmacol. 2010 Dec;161(7):1441-3. doi: 10.1111/j.1476-5381.2010.00980.x.

14.

K201, a multi-channel blocker, inhibits clofilium-induced torsades de pointes and attenuates an increase in repolarization.

Hasumi H, Matsuda R, Shimamoto K, Hata Y, Kaneko N.

Eur J Pharmacol. 2007 Jan 19;555(1):54-60. Epub 2006 Oct 17.

PMID:
17112502
15.

Understanding drug-induced torsades de pointes: a genetic stance.

Kannankeril PJ.

Expert Opin Drug Saf. 2008 May;7(3):231-9. doi: 10.1517/14740338.7.3.231 . Review.

PMID:
18462182
16.

Prolongation in QT interval is not predictive of Ca2+-dependent arrhythmias: implications for drug safety.

Pasquié JL, Richard S.

Expert Opin Drug Saf. 2009 Jan;8(1):57-72. doi: 10.1517/14740330802655454 . Review.

PMID:
19236218
17.

Magnitude of QT prolongation associated with a higher risk of Torsades de Pointes.

Lin YL, Kung MF.

Pharmacoepidemiol Drug Saf. 2009 Mar;18(3):235-9. doi: 10.1002/pds.1707.

PMID:
19145580
18.

Drug-induced torsades de pointes--a form of mechano-electric feedback?

Fabritz L.

Cardiovasc Res. 2007 Nov 1;76(2):202-3. Epub 2007 Aug 30. No abstract available.

PMID:
17869232
19.

Methadone-induced long QT syndrome vs methadone-induced torsades de pointes.

Justo D.

Arch Intern Med. 2006 Nov 13;166(20):2288; author reply 2289-90. No abstract available.

PMID:
17101953
20.

QT interval: a measure of drug action.

Woosley RL, Sale M.

Am J Cardiol. 1993 Aug 26;72(6):36B-43B. Review.

PMID:
8256753

Supplemental Content

Support Center